Cargando…
Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity
BACKGROUND: Increased susceptibility to 5‐fluorouracil (5‐FU)/capecitabine can lead to rapidly occurring toxicity caused by impaired clearance, dihydropyrimidine dehydrogenase deficiency, and other genetic variations in the enzymes that metabolize 5‐FU. Life‐threatening 5‐FU overdoses occur because...
Autores principales: | Ma, Wen Wee, Saif, Muhammad Wasif, El‐Rayes, Bassel F., Fakih, Marwan G., Cartwright, Thomas H., Posey, James A., King, Thomas R., von Borstel, Reid W., Bamat, Michael K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248610/ https://www.ncbi.nlm.nih.gov/pubmed/27622829 http://dx.doi.org/10.1002/cncr.30321 |
Ejemplares similares
-
Oral Capecitabine Exposures and Use of Uridine Triacetate: A 20-Year Retrospective Analysis
por: Seltzer, Justin A., et al.
Publicado: (2023) -
Uridine triacetate for severe 5-fluorouracil toxicity in a patient with thymidylate synthase gene variation: Potential pharmacogenomic implications
por: Baldeo, Candice, et al.
Publicado: (2018) -
Case report: Uridine triacetate in the management of delayed onset 5-fluorouracil toxicity: A case report and review of literature
por: Jacob, Aasems, et al.
Publicado: (2022) -
Uridine Triacetate for Severe Fluoropyrimidine Cardiotoxicity in a Patient With Thymidylate Synthase Gene Variants
por: Raber, Inbar, et al.
Publicado: (2020) -
Hypokalemia secondary to capecitabine: a hidden toxicity?
por: Saif, Muhammad Wasif, et al.
Publicado: (2007)